Search results for: 'distributed duti of service drug'

Small molecules, which are the leading drug class across indications, face several issues that threaten their drug delivery efficacy. They suffer from off-target effects, poor bioavailability, low solubility, systemic toxicity, and poor permeability. While the small molecule drug development pipeline remains a leading therapeutic class, it is essen...

The distribution infrastructure and delivery sector is undergoing a profound transformation, driven by the explosive growth of digital content consumption, the proliferation of edge computing, and the relentless evolution of security threats in an increasingly interconnected world. The focus in this sector has shifted from simply moving data effici...

This study examines the global distribution transformer market, analyzing demand drivers, technological trends, and competitive dynamics across key regions. It explores how rising electricity consumption, grid modernization programs, and the integration of distributed energy resources are reshaping replacement and new‑build requirements for distrib...

10 Aug 2022  |  Global  |  Market Outlook

Global Medium- and Heavy-duty Commercial Vehicle Aftermarket Outlook, 2022

Average Miles Driven and Spend per Vehicle to Rise Sharply and Result in Transformational Growth

Infographics

×

In 2021, the aftermarket rebounded strongly from the COVID-19 pandemic of 2020, as vehicles in operation (VIO), average miles driven, and spend per vehicle increased. However, parts shortages remain a year after the global economy has reopened, and the skilled labor shortage of truck drivers and service technicians is approaching critical levels. T...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

The discovery of new drug targets for diseases with unmet medical needs has long been hindered by the complexity of processing and interpreting massive volumes of biological data. The increasing volume and veracity of clinical and research data compels the use of enabling tools and technologies, such as cloud computing, AI, machine learning, natura...

For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development. Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges. With growing interest in ...

The SynBio field has evolved well over the past two decades, with significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening ...

The North American medium and heavy-duty commercial vehicle (CV) electronic service tools (EST) market is experiencing gradual and sustained growth, driven by interesting industry dynamics, such as advancements in vehicle complexity, a growing focus on vehicle efficiency and fuel economy, the increasing demand for a well-rounded fleet management pa...